Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer
暂无分享,去创建一个
Y. Niu | Z. Shang | Zhun Wang | Hui Xie | Linpei Guo | Shuang Peng | Qianwang Ma | Zhao Yang | S. Peng
[1] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[2] Carolyn Allen,et al. Thymidine kinase 1 through the ages: a comprehensive review , 2020, Cell & bioscience.
[3] B. Xu,et al. High intratumoral CD8+ T‐cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy , 2020, The Prostate.
[4] I. Melero,et al. Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies. , 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[5] Jianbin Bi,et al. Identification of core genes associated with prostate cancer progression and outcome via bioinformatics analysis in multiple databases , 2020, PeerJ.
[6] S. Ponnazhagan,et al. Revisiting Immunotherapy: A Focus on Prostate Cancer , 2020, Cancer Research.
[7] G. Curigliano,et al. Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial , 2020, Clinical Cancer Research.
[8] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[9] Beibei Ru,et al. TISIDB: an integrated repository portal for tumor-immune system interactions , 2019, Bioinform..
[10] Arvindhan G. Nagarajan,et al. Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression , 2019, PLoS genetics.
[11] James A. Eddy,et al. The Immune Landscape of Cancer. , 2019, Immunity.
[12] Gang Chen,et al. Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis , 2019, Aging.
[13] M. Piccart,et al. Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT). , 2019, European journal of cancer.
[14] Zemin Zhang,et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..
[15] Olga Tanaseichuk,et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.
[16] Simon G. Coetzee,et al. ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis , 2018, Nature Medicine.
[17] Stephen R. Piccolo,et al. Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies , 2018, Cancer Cell International.
[18] Keqin Zhang,et al. Serum thymidine kinase 1 is associated with Gleason score of patients with prostate carcinoma. , 2018, Oncology letters.
[19] Martin Shaw,et al. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker. , 2018, Biomarkers in medicine.
[20] Zhi-Tong Bing,et al. RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer , 2018, EBioMedicine.
[21] E. He,et al. Serological TK1 predict pre-cancer in routine health screenings of 56,178 people. , 2018, Cancer biomarkers : section A of Disease markers.
[22] A. Holland,et al. The impact of mitotic errors on cell proliferation and tumorigenesis , 2018, Genes & development.
[23] M. Nykter,et al. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression , 2018, Nature Communications.
[24] Johannes Zimmermann,et al. Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis , 2018, Journal of Immunotherapy for Cancer.
[25] Jun S. Liu,et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. , 2017, Cancer research.
[26] Hancheng Zheng,et al. Platinum Priority – Prostate CancerEditorial by XXX on pp. x-y of this issueWhole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression , 2017 .
[27] R. Madan,et al. Immunotherapy of Prostate Cancer: Facts and Hopes , 2017, Clinical Cancer Research.
[28] M. Rubin,et al. The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics. , 2017, European urology.
[29] U. Haberkorn,et al. New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy , 2016, Clinical Cancer Research.
[30] Steven J. M. Jones,et al. The Molecular Taxonomy of Primary Prostate Cancer , 2015, Cell.
[31] M. Fischer,et al. The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes , 2015, Nucleic acids research.
[32] S. Vowler,et al. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study , 2015, EBioMedicine.
[33] L. Hansson,et al. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker , 2015, BMC Cancer.
[34] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[35] T. Peretz,et al. Serum Thymidine Kinase 1 Activity in the Prognosis and Monitoring of Chemotherapy in Lung Cancer Patients: A Brief Report , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[36] R. Ferraldeschi,et al. Evolution of androgen receptor targeted therapy for advanced prostate cancer , 2014, Nature Reviews Clinical Oncology.
[37] Michael J. Barry,et al. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. , 2014, JAMA.
[38] R. Robison,et al. Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation , 2012, Journal of oncology.
[39] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[40] Benjamin J. Raphael,et al. The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer , 2012, Nature.
[41] E. Lundberg,et al. Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.
[42] C. Sander,et al. Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.
[43] Yen-Ling Chen,et al. Regulation and Functional Contribution of Thymidine Kinase 1 in Repair of DNA Damage* , 2010, The Journal of Biological Chemistry.
[44] Y. Li,et al. Thymidine Kinase 1 is a Potential Marker for Prognosis and Monitoring the Response to Treatment of Patients with Breast, Lung, and Esophageal Cancer and Non-Hodgkin's Lymphoma , 2010, Nucleosides, nucleotides & nucleic acids.
[45] K. Johansson,et al. Structure and function of cellular deoxyribonucleoside kinases , 2002, Cellular and Molecular Life Sciences CMLS.
[46] E. Diamandis. Prostate-specific Antigen: Its Usefulness in Clinical Medicine , 1998, Trends in Endocrinology & Metabolism.
[47] T. Jacks,et al. The cell cycle and cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[48] L. Johnson,et al. Regulation of thymidine kinase enzyme level in serum-stimulated mouse 3T6 fibroblasts. , 1982, Experimental cell research.
[49] L. Bello,et al. Regulation of thymidine kinase synthesis in human cells. , 1974, Experimental cell research.
[50] Amareshwar T. K. Singh,et al. Cell-cycle Checkpoints and Aneuploidy on the Path to Cancer. , 2018, In vivo.
[51] S. Skog,et al. Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer. , 2005, Oncology reports.
[52] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..